This document is an Applicant Declaration from menovex Medical Technology (Shenzhen) Co., Ltd., submitted to SGS North America Inc. for FCC equipment authorization. The declaration confirms the applicant's adherence to FCC regulations, including accurate labeling, compliance with technical rules, and post-market surveillance requirements. It also addresses the applicant's responsibilities as defined in 47 CFR 2.909 and KDB394321, as well as ISO 17065, FCC KDB641163, FCC KDB610077, KDB394321 and RSP-100.
The declaration further states that neither the applicant nor any party involved is subject to a denial of Federal benefits, including FCC benefits, under Section 5301 of the Anti-Drug Abuse Act of 1988. It also confirms that the equipment for which authorization is sought is not "covered" equipment prohibited by FCC rules and does not contain cybersecurity or anti-virus software produced by Kaspersky Lab, Inc. The document is signed by Qin Xueying, Regulatory Affairs Supervisor, on January 2, 2025.
File Info : application/pdf, 1 Pages, 937.65KB
DownloadDocument